Biocon Biologics secures FDA approval for cancer drug Jobevne
[ad_1] The shares of Biocon Biologics Ltd were trading at ₹316.4 up by ₹10.15 or 3.31 per cent on the NSE today at 11 am.
Zydus gains FDA approval for urinary tract infection medication
[ad_1] Zydus Lifesciences Limited announced today it has received final approval from the US Food and Drug Administration (USFDA) to manufacture Methenamine Hippurate Tablets USP,
